Changes in the relaxation and filling properties of the left ventricle (LV) in cardiac hypertrophy and heart failure (HF) have been recognized for decades (2, 3) . Some of these include alterations in the speed and/or extent of myofilament deactivation. Thus, in patients with heart failure with reduced ejection fraction (HFrEF), abnormalities in both Na-Ca handling (4) and acto-myosin kinetics (5) lead to slowed and/or incomplete relaxation. Impaired myofilament deactivation due to abnormal Na-Ca handling and slowed acto-myosin kinetics has also been reported in patients with hypertension (HTN), concentric LV remodeling, and heart failure with preserved ejection fraction (HFpEF) (6, 7) .
Altered passive filling properties of the myocardium are also prominent in cardiac hypertrophy and HF. These are determined by the combined effects of collagen and titin, the giant myofilament spring protein that accounts for cardiomyocyte stiffness over the physiological sarcomere length range (8, 9 ).
Titin's contribution can be modulated by isoform variation and phosphorylation (10, 11) . The splice factor RBM20 is responsible for generation of 2 isoforms: the larger, more compliant N2BA, and the smaller N2B isoform (12) . Titin phosphorylation occurs at multiple sites in its N2B and PEVK segments (10, 11) . Protein kinase (PK) A and PKG are active at the same sites; PKC-a is active at different sites. PKA/PKG reduces and PKC-a phosphorylation increases titin stiffness. Phosphorylation can rapidly alter titin and myocardial passive stiffness, for example, during exercise. Other kinases that phosphorylate titin (e.g., ERK2) and other post-translational modifications (e.g., disulfide bond formation) have been reported (10, 11) . These may be significant in human disease and are an emerging research focus. Recently, aggregation of titin was shown to contribute to elevated cardiomyocyte stiffness in AS and HFrEF (13) .
Changes in determinants of passive stiffness have been reported in nonischemic dilated cardiomyopathy (HFrEF). Collagen content is increased (14, 15) . Titin undergoes a shift to the N2BA isoform that decreases its stiffness (14) (15) (16) , but a concomitant decrease in N2B phosphorylation (presumably PKA/PKG sites) serves to increase stiffness. Passive myocardial stiffness is decreased in HFrEF (15) , which implies that the titin isoform shift is the single most important change. Science author instructions page. 
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Collagen content/fibrosis is increased in AS (23),
and it is believed that passive myocardial stiffness is increased (although it has never been measured).
However, relatively little is known about titin. However, these biopsies are limited to patients undergoing cardiac surgery. Thus, as discussed, we have studied coronary bypass surgery patients (9) . As pointed out by Gotzmann et al. (1) , human biopsy methods are subject to sampling error because it is usually only possible to biopsy 1 site. Last, identifying suitable control subjects can be problematic.
Brain-dead patients, as used by Gotzmann et al. (1),
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